⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABSI News
Absci Corporation Common Stock
Form 8-K
sec.gov
ABSI
Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors
globenewswire.com
ABSI
Form 8-K
sec.gov
ABSI
Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)
globenewswire.com
ABSI
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It
prnewswire.com
HYFT
SDGR
RXRX
ABSI
CERT
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery
businesswire.com
HYFT
ABSI
Treg Cell-Based Therapies Clinical Trial Pipeline Appears Robust With 29+ Key Pharma Companies Actively Working in the Domain | DelveInsight
globenewswire.com
RAPT
SANG
INCY
ABBV
ARCT
AMGN
CHKP
PFE
LLY
SCLX
SNY
UCB
BIIB
NVS
VTRS
BMY
ABSI
ALEC
GSK
IONS
CLNN
ANNX
MED
GAM
VRTX
EXC
BLRX
Form 8-K
sec.gov
ABSI
Absci to Participate in Upcoming Investor Conferences
globenewswire.com
ABSI
Masitinib Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
globenewswire.com
ABSI